I believe that future legal challenges will lead to the invalidation of many parts of Dodd-Frank.
Pat Toomey
The Public Record
Patrick Toomey is a former United States Senator from Pennsylvania, serving from 2011 to 2022. A member of the Republican Party, Toomey was known for his focus on fiscal conservatism, economic growth, and limited government. During his tenure, he served on several Senate committees, including the Banking, Housing, and Urban Affairs Committee, where he was involved in financial regulation and economic policy discussions.
The drafters of Dodd-Frank immunized, I believe, the Bureau from any meaningful Congressional influence, leaving it free to engage in questionable practices and unreasonable expansions of its jurisdiction.
that conveys an intelligible direction to the marketplace so as to create deterrence that can be readily understood and implemented.
in the case in which you guys discovered discrimination on the basis of protected class being committed by people who were not aware of the protected class status of the people they were supposedly discriminating against, you are applying…
I think everybody would agree that basic fairness in law enforcement is that if person A or institution, bank A, say, is doing these things and they are found to violate the law, an action has to be taken in consequence.
I have said many times that regulatory independence should never mean independence from accountability or vigorous Congressional oversight.
Your legislation would address this problem head on by stopping the epidemic where it starts--at the pharmacy counter.
We urge the Senate to appropriately respond to the epidemic of opioid addiction and overdose deaths by passing this legislation.
We urge the Senate to help address the nation's prescription drug abuse epidemic by passing the Stopping Medication Abuse and Protecting Seniors Act of 2015.
the legislation that we are discussing today would dramatically reduce the chances that people could obtain multiple prescriptions from multiple providers
Your bill directly addresses concerns about the harmful impact of prescription drug fraud and abuse on the health and well-being of Medicare beneficiaries.





